Piper Sandler News Releases


News Releases  |  In the News

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Piper Jaffray & Co. is pleased to announce that Mark E. Karvosky has joined the firm as a vice president and senior research analyst in healthcare covering biotechnology companies. Karvosky will be based in the firm's New York office.

"We are excited to have Mark join our extensive health care platform," said Mike Ott, head of Equity Research at Piper Jaffray. "Mark brings tremendous experience and academic background to our biotechnology coverage."

Karvosky joins Piper Jaffray from Prudential Equity Group in New York, where he was a senior biotechnology research analyst. Prior to Prudential, Karvosky spent two years as a research coordinator at Harvard Medical School's Department of Physical Medicine and Rehabilitation in Boston. He earned his bachelor and master's degrees at Wesleyan University in Middletown, Conn., in neuroscience and behavior.

Headquartered in Minneapolis, Piper Jaffray & Co., a subsidiary of Piper Jaffray Companies (NYSE: PJC), is a focused securities firm dedicated to delivering superior financial advice, investment products and transaction execution within selected sectors of the financial services marketplace. The company operates through two primary revenue-generating segments - Capital Markets and Private Client Services. Investment Research, an independent group reporting to the CEO, supports clients of both segments. The firm serves corporations, government and non-profit entities, and institutional investors on a national basis and serves the financial advisory needs of private individuals predominantly across the western half of the United States. The firm has over 2900 employees in 111 offices in 23 states across the country and in London, England. For more information about Piper Jaffray, visit us online at .

Since 1895. Member SIPC and NYSE.

SOURCE  Piper Jaffray & Co.
CONTACT:  Susan Beatty, Public Affairs and Media Relations of Piper
Jaffray, +1-612-303-5680
Web site: